EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ICOS regulates IL-10 production in group 2 innate lymphoid cells via cholesterol and cortisol biosynthesis

Yoshihiro Sakano, Kei Sakano, Benjamin P Hurrell, Mohammad H Kazemi, Xin Li, Stephen Shen, Omid Akbari

Journal of Clinical Investigation · 2025

DOI: 10.1172/jci193134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Yoshihiro Sakano und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Cholesterol, Hydrocortisone, Interleukin-10, Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, Foundation for the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Group 2 innate lymphoid cells (ILC2s) play a crucial role in inducing type 2 inflammation in the lungs in response to allergens. Our study investigated the regulatory mechanism of IL-10 production by ILC2s and its impact on airway hyperreactivity (AHR), focusing on the role of ICOS. We found that inhibiting ICOS in pulmonary ILC2s significantly enhanced IL-10 production. The absence of ICOS reprogrammed ILC2 steroid metabolism, leading to increased cholesterol and cortisol biosynthesis and subsequent glucocorticoid receptor (GR) activation. This reprogramming regulated MAF and NFIL3 activation, promoting IL-10 production. Notably, in vivo GR inhibition or ILC2-specific GR deficiency exacerbated AHR development in multiple mouse models. We extended these findings to human ILC2s, demonstrating concordant results between murine models and human cells. Our results indicate that ICOS negatively regulates IL-10 production in ILC2s by controlling cholesterol and cortisol biosynthesis. This mechanism provides new insights into the complex interplay between ILC2s, ICOS, and glucocorticoid signaling in the context of allergic airway inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholesterolHydrocortisoneInterleukin-10LymphocytesInducible T-Cell Co-Stimulator ProteinImmunity, InnateAnimalsMiceHumansMice, KnockoutReceptors, Glucocorticoid

Stichwörter der Autor:innen

AllergyAsthmaCholesterolImmunologyPulmonology

Substanzen

CholesterolHydrocortisoneInterleukin-10Inducible T-Cell Co-Stimulator ProteinIcos protein, mouseIL10 protein, mouseReceptors, GlucocorticoidIL10 protein, human

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • Foundation for the National Institutes of Health

Zitieren

APA

Sakano, Y., Sakano, K., Hurrell, B. P., Kazemi, M. H., Li, X., Shen, S., & Akbari, O. (2025). ICOS regulates IL-10 production in group 2 innate lymphoid cells via cholesterol and cortisol biosynthesis. Journal of Clinical Investigation. https://doi.org/10.1172/jci193134

Vancouver

Sakano Y, Sakano K, Hurrell BP, Kazemi MH, Li X, Shen S, et al. ICOS regulates IL-10 production in group 2 innate lymphoid cells via cholesterol and cortisol biosynthesis. Journal of Clinical Investigation. 2025. doi:10.1172/jci193134

BibTeX
@article{Sakano2025,
  author = {Sakano, Yoshihiro and Sakano, Kei and Hurrell, Benjamin P and Kazemi, Mohammad H and Li, Xin and Shen, Stephen and Akbari, Omid},
  title = {ICOS regulates IL-10 production in group 2 innate lymphoid cells via cholesterol and cortisol biosynthesis},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci193134}
}
Kostenlos starten →